No insider purchase over the last 90 days. The latest was filed 05 Dec 2021.
EXACT Therapeutics AS is a Health Care company. Its directors and officers file their transactions with Oslo Børs. Between 18 October 2025 and 18 October 2026, 2 insiders published 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 258 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 1 purchase and no sales.
Insider buying of EXACT Therapeutics AS has been absent for the past year.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
FY ended December 2025 · cache
13 of 13 declarations
EXACT Therapeutics AS is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on the XOSL market.
Purchases our model currently ranks for the recommendations list.
All recommendations